Coeptis Therapeutics, Inc. Retained Earnings
Coeptis Therapeutics, Inc. had Retained Earnings of -$62.18 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-08
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$62.18M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$56.53M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$46.73M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$27.55M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2022-09-30 | -$62.18M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$56.53M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | -$46.73M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$27.55M 10-Q · filed 2022-11-08 | |
| 2021-09-30 | -$24.71M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$18.76M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$16.05M 10-Q/A · filed 2021-05-18 | |
| 2020-12-31 | -$14.10M 10-K · filed 2022-03-11 | -$590.39K 10-KT · filed 2021-05-11 |
| 2020-11-30 | -$526.09K 10-Q · filed 2021-01-11 | |
| 2020-08-31 | -$36.85K 10-Q/A · filed 2020-11-23 | |
| 2020-02-29 | -$13.40K 10-Q · filed 2021-01-11 | |
| 2019-12-31 | -$150.00 10-KT · filed 2021-05-11 |